Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Mark Sloan

Boston University Chobanian & Avedisian School of Medicine, Boston
U.S.A
Publications

A Prospective, Single-Center, Randomized Phase 2 Trial of Etoposide in Severe COVID-19

The systemic inflammatory response seen in patients with severe COVID-19 shares many similarities with the changes observed in Hemophagocytic Lymphohistiocytosis (HLH); a disease characterized by excessive immune activation. Many patients with severe COVID qualify for a diagnosis of HLH. Etoposide, an inhibitor of topoisomerase II is used to contro... Read More»

Meredith Halpin, Adam Lerner, Manish Sagar, Praveen Govender, Bhavesh Shah RPH BCOP, Janice Weinberg ScD, Shayna Sarosiek MD and Mark Sloan

: J Infect Dis Ther

10.4173/2332-0877.23.S4.001

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article

Top